Metered-dose inhaler budesonide-glycopyrrolate-formoterol (Breztri Aerosphere) was associated with a higher risk of a first moderate or severe COPD exacerbation (HR 1.09, 95% CI 1.04-1.14 ...

DOI: 10.1136/bmj-2024-080409 Meng-Ting Wang et al, Environmentally friendly inhaler regimens for COPD, BMJ (2024). DOI: 10.1136/bmj.q2825 ...

A study compares budesonide-glycopyrrolate-formoterol and fluticasone-umeclidinium-vilanterol, revealing insights on COPD ...

In a cohort of adults with chronic obstructive pulmonary disease (COPD), receiving fluticasone-umeclidinium-vilanterol was ...

Emphysema More Common in Marijuana ... Symptoms in People Without COPD Sep. 5, 2022 — Researchers have found that dual bronchodilators -- long-lasting inhalers that relax the airways and make ...

AstraZeneca may mount a challenge to GlaxoSmithKline’s three-in-one inhaler for chronic obstructive pulmonary disease (COPD) after a late-stage trial success. AZ’s single inhaler, PT010 ...

COPD is only partially reversible in that ... in order of frequency of occurrence: One of the most common symptoms of inhaled ...

while another thousand were given the most common globally used inhaler. A further 500 were given the triple combination but in two inhalers. COPD is term used to describe a number of progressive lung ...

Poor adherence to treatment is a common issue in COPD patients and frequently results ... to partner with in the development of smart inhalers. Virtually all the companies active in the ...

Budesonide-glycopyrrolate-formoterol does not improve clinical outcomes compared with fluticasone-umeclidinium-vilanterol ...

Medscape Medical News, August 08, 2023 Study Questions Use of Branded Inhalers for COPD Researchers said their analysis found that a generic product approved in 2019 was equally effective as the ...